Investor Update

Reminder: Invitation to Roche’s First Quarter Sales 2021 Webinar

Q1 image 315110_v2


Roche will publish its Sales Results for the 1st Quarter of 2021 prior to the opening of the Swiss Stock Exchange on Wednesday, 21 April 2021.

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here.
Presentation slides will be posted on the Roche IR website > click here

14:00 - 15:30 CEST / 13:00 - 14:30 BST
08:00 - 09:30 AM EDT / 05:00 - 06:30 AM PDT

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.



A replay of the webcast will be available via > ir.roche.com
*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations and Roche Group Planning


Roche Investor Relations 
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
  
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com